{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T07:09:20Z","timestamp":1795158560787,"version":"4.10.3"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"suppl C","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Heart Journal"],"published-print":{"date-parts":[[1989,8,2]]},"DOI":"10.1093\/eurheartj\/10.suppl_c.25","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T17:37:52Z","timestamp":1353346672000},"page":"25-31","source":"Crossref","is-referenced-by-count":33,"title":["Pharmacology of positive inotropic phosphodiesterase III inhibitors"],"prefix":"10.1093","volume":"10","author":[{"given":"P.","family":"Honerjager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/10\/suppl_C\/25\/1230562\/10-suppl_C-25.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T22:42:01Z","timestamp":1503441721000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/10.suppl_C.25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,8,2]]},"references-count":0,"journal-issue":{"issue":"suppl C","published-print":{"date-parts":[[1989,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/10.suppl_c.25","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,8,2]]}}}